Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial
(Q82779804)
scientific article published on 01 March 2006
scientific article published on 01 March 2006
Language:
Current Data About
Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial
other details
description | scientific article published on 01 March 2006 |
External Links
(P356) |
10.1016/J.CGH.2005.11.013
|
(P698) |
16527696
|